Herein, we report that TFF3 secreted from mammary carcinoma cells promotes de novo angiogenesis, both directly by TFF3 stimulation of endothelial cells and indirectly via enhanced IL-8 expression, which subsequently regulates endothelial cell function. Here, CXCL8 is linked to breast carcinoma.